CARR EDWARD bought DNTH
February 3, 2026 · Form 4 insider transaction
CARR EDWARD bought 55,000 shares of Dianthus Therapeutics, Inc. at $0.00 per share, a transaction worth N/A. The trade was recorded as grant or award and disclosed on an SEC Form 4, filed 1 day after the transaction.
Direction
Acquired (buy-side)
Shares
55,000
Price
$0.00
Total value
N/A
InsiderCARR EDWARD
RoleOfficer
SecurityStock Option (Right to Buy)
Transaction codeA: Grant or award
Transaction dateFebruary 3, 2026
Filing dateFebruary 4, 2026
Shares owned after55,000
OwnershipDirect
10b5-1 planNo
AmendedNo
Footnotes
The shares of common stock underlying this stock option award will vest in equal monthly installments over the four years after January 1, 2026, subject to the Reporting Person's continued service to the Issuer on each such vesting date.